STOCK TITAN

OPENLANE’s Charles S. Coleman sells 39,976 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

OPENLANE, Inc. EVP, CLO & Secretary Charles S. Coleman exercised options on November 10, 2026, for 29,006 shares at an $18.23 exercise price and 9,763 shares at $13.81, then sold the corresponding shares at a weighted-average $35.21 per share. On November 9, he exercised options for 903 shares at $18.23 and 304 shares at $13.81, and sold the corresponding shares at a weighted-average $35.01 per share.

The sale prices were weighted averages across transactions ranging from $35.00 to $35.44 on November 10 and $35.00 to $35.03 on November 9. No Rule 10b5-1 plan is reported.

Insider Coleman Charles S.
Role EVP, CLO & Secretary
Sold 39,976 shs ($1.41M)
Approx. gross sale proceeds $1.41M
Approx. exercise cost $684K
Approx. pre-tax spread $723K
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) F3 29,006 $18.23 $529K
Exercise Employee Stock Option (right to buy) F4 9,763 $13.81 $135K
Exercise Common Stock 29,006 $18.23 $529K
Sale Common Stock F2 29,006 $35.21 $1.02M
Exercise Common Stock 9,763 $13.81 $135K
Sale Common Stock F2 9,763 $35.21 $344K
Exercise Employee Stock Option (right to buy) F3 903 $18.23 $16K
Exercise Employee Stock Option (right to buy) F4 304 $13.81 $4K
Exercise Common Stock 903 $18.23 $16K
Sale Common Stock F1 903 $35.01 $32K
Exercise Common Stock 304 $13.81 $4K
Sale Common Stock F1 304 $35.01 $11K
Holdings After Transaction: Employee Stock Option (right to buy) — 0 options (Direct); Common Stock — 74,334 shares (Direct)
Footnotes (4)
  1. F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.03 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.44 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. These options were granted on June 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $23.23, $28.23, $33.23, and $38.23, for twenty consecutive trading days, subject to continued employment through such vesting date.
  4. F4. These options were granted on March 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $18.81, $23.81, $28.81, and $33.81, for twenty consecutive trading days, subject to continued employment through such vesting date.
Options exercised 29,006 shares November 10, 2026; $18.23 exercise price
Options exercised 9,763 shares November 10, 2026; $13.81 exercise price
Options exercised 903 shares November 9, 2026; $18.23 exercise price
Options exercised 304 shares November 9, 2026; $13.81 exercise price
Shares sold 39,976 shares Total reported sales on November 9 and 10, 2026
Weighted-average sale price $35.01 per share November 9, 2026; individual transactions ranged from $35.00 to $35.03
Weighted-average sale price $35.21 per share November 10, 2026; individual transactions ranged from $35.00 to $35.44
weighted average price financial
"The price reported in column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
eligible to vest technical
"became eligible to vest and became exercisable in equal 25% increments"
exercisable technical
"became eligible to vest and became exercisable in equal 25% increments"
consecutive trading days technical
"for twenty consecutive trading days"
Rule 10b5-1 plan regulatory
"No Rule 10b5-1 plan is reported"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OPLN shares did Charles S. Coleman sell?

Charles S. Coleman sold 39,976 shares across November 9 and 10, 2026. The weighted-average sale prices were $35.01 per share on November 9 and $35.21 on November 10, with trades on each date occurring within the price ranges reported for those sales. No Rule 10b5-1 plan is reported.

What conditions applied to Charles S. Coleman’s OPLN options?

The options granted June 4, 2021 and March 4, 2021 became eligible to vest and exercisable in equal 25% increments. Each increment depended on the later of the relevant grant anniversary and the stock reaching its specified closing-price threshold for 20 consecutive trading days, subject to continued employment. The thresholds were $23.23, $28.23, $33.23 and $38.23 for the June grant, and $18.81, $23.81, $28.81 and $33.81 for the March grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Coleman Charles S.

(Last)(First)(Middle)
C/O: OPENLANE, INC.
11299 NORTH ILLINOIS STREET

(Street)
CARMEL INDIANA 46032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OPENLANE, Inc. [ OPLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, CLO & Secretary
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/09/2026M903A$18.2375,237D
Common Stock11/09/2026S903D$35.01(1)74,334D
Common Stock11/09/2026M304A$13.8174,638D
Common Stock11/09/2026S304D$35.01(1)74,334D
Common Stock11/10/2026M29,006A$18.23103,340D
Common Stock11/10/2026S29,006D$35.21(2)74,334D
Common Stock11/10/2026M9,763A$13.8184,097D
Common Stock11/10/2026S9,763D$35.21(2)74,334D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$18.2311/09/2026M903 (3)06/04/2031Common Stock903$18.2329,006D
Employee Stock Option (right to buy)$13.8111/09/2026M304 (4)03/04/2031Common Stock304$13.819,763D
Employee Stock Option (right to buy)$18.2311/10/2026M29,006 (3)06/04/2031Common Stock29,006$18.230D
Employee Stock Option (right to buy)$13.8111/10/2026M9,763 (4)03/04/2031Common Stock9,763$13.810D
Explanation of Responses:
1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.03 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.44 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. These options were granted on June 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $23.23, $28.23, $33.23, and $38.23, for twenty consecutive trading days, subject to continued employment through such vesting date.
4. These options were granted on March 4, 2021 and became eligible to vest and became exercisable in equal 25% increments, each upon the later of the occurrence of the first four anniversaries of the grant date, respectively, and the attainment of the closing price of the Company's common stock at or above, for each respective 25% increment, $18.81, $23.81, $28.81, and $33.81, for twenty consecutive trading days, subject to continued employment through such vesting date.
Remarks:
Charles S. Coleman11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading